MAT2203

· Matinas BioPharma Nanotechnologies, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAT2203, covering 2024-06-07 to 2024-06-07. Get the full timeline:

Most recent: Clinical Trial Update: CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis [Phase 2]